Determination of the Critical Concentration of Rifabutin for Susceptibility Testing Using the Proportion Method with Löwenstein-Jensen Medium against Mycobacterium Tuberculosis Isolates

Lab Med. 2019 Jul 16;50(3):292-297. doi: 10.1093/labmed/lmy085.

Abstract

Objective: To determine the critical concentration of rifabutin (RFB) for susceptibility testing against Mycobacterium tuberculosis (Mtb) on Löwenstein-Jensen (L-J) medium using the proportion method.

Methods: We used 47 strains were used to determine the critical concentration of RFB. The microplate antimicrobial assay (MABA) was used as a reference method. We used 160 strains to evaluate its correlation with the classification results derived from the MABA method. We performed antimicrobial susceptibility testing (AST) against RFB and rifampin (RIF) for 2748 other strains using the proportion method on L-J medium.

Results: The determined critical concentration for RFB was 20 μg per mL. Identical classification as susceptible or resistant was observed in 93.8% and 92.5% strains for RFB and RIF, respectively, using the 2 different methods. The cross-resistance ratio between RFB and RIF was 72.7% in the 2748 Mtb strains.

Conclusions: We determined that a critical concentration of 20 μg per mL RFB was reliable for AST of Mtb.

Keywords: Mycobacterium tuberculosis; L-J medium; critical concentration; proportion method; rifabutin; rifampin.

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Clinical Trial, Phase III

MeSH terms

  • Antibiotics, Antitubercular / pharmacology*
  • Culture Media / chemistry*
  • Microbial Sensitivity Tests / methods*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / growth & development*
  • Rifabutin / pharmacology*
  • Rifampin / pharmacology

Substances

  • Antibiotics, Antitubercular
  • Culture Media
  • Rifabutin
  • Rifampin